Board & Council Members Van Andel Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute John Kennedy President & Chief Executive Officer, Autocam Medical Mark Meijer President, Life E.M.S. Ambulance Van Andel Research Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute Tom R. DeMeester, M.D. Professor & Chairman Emeritus, Department of Surgery, Keck School of Medicine, University of Southern California James B. Fahner, M.D. Chief of Hematology & Oncology, Helen DeVos Children’s Hospital (LEFT TO RIGHT) MARK MEIJER, JOHN KENNEDY & DAVID VAN ANDEL. 42 | VAN ANDEL INSTITUTE ANNUAL REPORT 2017 Michelle Le Beau, Ph.D. Professor of Medicine, Section of Hematology/Oncology; Director, University of Chicago Comprehensive Cancer Center; Director, Cancer Cytogenetics Laboratory, University of Chicago George Vande Woude, Ph.D. Distinguished Scientific Fellow, Founding Research Director, Van Andel Research Institute Ralph Weichselbaum, M.D. Chairman, Department of Radiation; Head, Ludwig Center for Metastasis Research, University of Chicago Max S. Wicha, M.D. Distinguished Professor of Oncology; Professor, Department of Internal Medicine; Founding Director, University of Michigan Comprehensive Cancer Center (LEFT TO RIGHT) JUAN OLIVAREZ, DAVID VAN ANDEL, GORDON VAN HARN & JAMES BULTMAN. (NOT PICTURED) DONALD MAINE. Van Andel Education Institute Trustees David Van Andel Chairman & Chief Executive Officer, Van Andel Institute James E. Bultman, Ed.D. Former President, Hope College Donald W. Maine Former President, Davenport University Juan R. Olivarez, Ph.D. President, Aquinas College Gordon L. Van Harn, Ph.D. Emeritus Provost & Professor of Biology, Calvin College
Van Andel Research Institute Board of Scientific Advisors Michael Brown, M.D. (Chair) Paul J. Thomas Professor of Genetics & Director of the Jonsson Center of Molecular Genetics, University of Texas Southwestern Medical Center Richard Axel, M.D. Professor of Neurosciences, Columbia University Joseph L. Goldstein, M.D. Chairman of the Department of Molecular Genetics, University of Texas Southwestern Medical Center Tony Hunter, Ph.D. Professor, Molecular & Cell Biology Laboratory; American Cancer Society Professor; Renato Dulbecco Chair; Director, Salk Institute Cancer Center Philip A. Sharp, Ph.D. Professor of Biology & Head of the Cancer Center, Massachusetts Institute of Technology Van Andel Research Institute External Scientific Advisory Board Tony Hunter, Ph.D. (Chair) Professor, Molecular & Cell Biology Laboratory; American Cancer Society Professor; Renato Dulbecco Chair; Director, Salk Institute Cancer Center Marie-Francois Chesselet, M.D., Ph.D. Charles H. Markham Professor of Neurology; Distinguished Professor of Neurology and of Neurobiology, Reed Neurological Research Center Howard J. Federoff, M.D., Ph.D. Vice Chancellor for Health Affairs; Dean of Medicine, University of California Irvine Theresa Guise, M.D. Professor of Medicine; Jerry W. & Peg S. Throgmartin Professor of Oncology, Department of Medicine, Division of Endocrinology, Indiana University Kristian Helin, Ph.D. Director, Biotech Research & Innovation Centre (BRIC); Professor, Faculty of Health Sciences, University of Copenhagen Sharon Y.R. Dent, Ph.D. Professor and Chair, Department of Epigenetics and Molecular Carcinogenesis; Director, Science Part; Director, Center for Cancer Epigenetics, MD Anderson Cancer Center Max S. Wicha, M.D. Distinguished Professor of Oncology; Professor, Department of Internal Medicine; Founding Director, University of Michigan Comprehensive Cancer Center Van Andel Education Institute Advisory Council David Van Andel Chairman & Chief Executive Officer, Van Andel Institute Nancy Ayres Former General Manager, Flexco Stephen Best Education Consultant, Michigan Department of Education James Boelkins, Ph.D. Former Provost, Hope College LEADERSHIP Joseph Krajcik, Ph.D. Professor, Department of Teacher Education at Michigan State University Carol Van Andel, B.A. Executive Director, David & Carol Van Andel Family Foundation Van Andel Institute Graduate School Board of Directors James Fahner, M.D. Chief of Hematology & Oncology, Helen DeVos Children’s Hospital Michael J. Imperiale, Ph.D. Director, Doctoral Program in Cancer Biology; Associate Chair, Department of Microbiology & Immunology, University of Michigan Peter Jones, Ph.D., D.Sc. Chief Scientific Officer, Van Andel Research Institute Pamela Kidd, M.D. Hematopathologist & Medical Director of the Hematology & Flow Cytometry Laboratories, Spectrum Health & Helen DeVos Children’s Hospital Gordon Van Harn, Ph.D. Emeritus Provost & Professor of Biology, Calvin College VAN ANDEL INSTITUTE ANNUAL REPORT 2017 | 43
Loading...
Loading...
Loading...
Established by Jay and Betty Van Andel in 1996, Van Andel Institute is committed to improving the health and changing the lives of current and future generations, through biomedical research and science education.
Van Andel Institute is a tax-exempt 501(c)(3) charitable organization. EIN 52-2000820
Van Andel Institute is committed to making our website’s content accessible and user friendly to everyone. If you are interested in applying for employment with Van Andel Institute and need special assistance or an accommodation to complete our application process, are having difficulty viewing or navigating the content on this website, or notice any content, feature, or functionality that you believe is not fully accessible to people with disabilities, please call the Human Resources Department at 616-234-5100 or email at vari-employment@vai.org.
Van Andel Institute is an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans.